BioAdvance - Press Releases
Newsroom >> News Releases

News Releases

2010   |   2009   |   2008   |   2007   |   2006   |   2005   |   2004   |   2003   |   2002   |   2001

2004

November 19, 2004

Anti-Cancer Vaccine Licensed by Alteris Doubles Time-to-Disease Progression and Increases Survival in Phase I Brain Cancer Trial
> View Press Release
October 26, 2004

Yaupon Therapeutics Initiates Clinical Trials for First Agent to Treat Epidemic of Methamphetamine Addiction
> View Press Release
October 7, 2004

BioAdvance Portfolio Company Acuity Pharmaceuticals Leapfrogs From Seed Funding to Major Milestones.
> View Press Release
September 21, 2004

BioAdvance Ventures Announces Closing of $26 Million Early Stage Life Sciences Fund.
> View Press Release
July 22, 2004

Pennsylvania Bio Applauds Selection of Greenwood to Head BIO.
> View Press Release
July 8, 2004

BioAdvance Launches Third Investment Cycle.
> View Press Release
June 7, 2004

BioAdvance Organizes a Bio 2004 Panel on Regional Life Sciences Economic Development Efforts.
> View Press Release
April 19, 2004

BioAdvance Announces Acquisition of Greenhouse Recipient Gelifex By Leading Orthopedics Firm
> View Press Release
February 23, 2004

Cira Discovery Sciences and The Wistar Institute Announce Collaboration to Develop New Approaches to Proteomics-Based Diagnostics
> View Press Release
February 18, 2004

Alteris Licenses Rights from Duke And Johns Hopkins to Cancer Vaccine Targeting Variant EGF Receptor
> View Press Release